In today’s fast-paced stock market, understanding the subtle cues of technical analysis is key to smart investing.
In this article, we focus on Tianjin Pharmaceutical Da Re Tang Group Corp Ltd (SGX: T14), whose price action is indicating a potential end to a downward correction and a return to the upside.
Below are some key highlights from the technical report:
- Market Position: Tianjin Pharma is designated as a ‘Technical Buy’ at the last price of US$1.98.
- Entry Prices and Support Levels: Suggested entry prices are US$1.98, US$1.84 and US$1.72, with key supports at US$1.85 and US$1.65.
- Stop Loss and Resistance Levels: A stop loss is advised at US$1.62, with resistance points at US$2.10 and US$2.30.
- Target Prices: The analysis sets target prices at US$2.28, US$2.46, US$2.66, and US$2.84.
- Company Overview: Tianjin Pharma produces and sells traditional Chinese medicine, western medicine, health products, and healthcare instruments.
For a more detailed analysis, click on the link to access the report.
Take advantage of the stock momentum
Our goal is simple: to provide you with clear, actionable insights from the complex world of stock charts and trends. Whether you’re a seasoned investor or just starting out, our analysis is designed to help you navigate the market with confidence.
Please refer to the attached report for the disclaimer.
